NCT00660985View on ClinicalTrials.gov

Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%

PHASE4CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

November 30, 2008

Conditions

Acne Vulgaris

Interventions

DRUG

Adapalene

Gel, 0.3%, 2g, once daily for 30 days

DRUG

Adapalene

Gel, 0.1%, 2g, once daily for 30 days

Trial Locations (2)

77845

J&S Studies, Inc., College Station

78759

DermResearch, Inc., Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY